59 related articles for article (PubMed ID: 22687250)
1. Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis.
Matsunaga S; Sawasaki T; Ode H; Morishita R; Furukawa A; Sakuma R; Sugiura W; Sato H; Katahira M; Takaori-Kondo A; Yamamoto N; Ryo A
J Proteomics; 2012 Aug; 75(15):4863-73. PubMed ID: 22687250
[TBL] [Abstract][Full Text] [Related]
2. NMR study of xenotropic murine leukemia virus-related virus protease in a complex with amprenavir.
Furukawa A; Okamura H; Morishita R; Matsunaga S; Kobayashi N; Ikegami T; Kodaki T; Takaori-Kondo A; Ryo A; Nagata T; Katahira M
Biochem Biophys Res Commun; 2012 Aug; 425(2):284-9. PubMed ID: 22842568
[TBL] [Abstract][Full Text] [Related]
3. Biochemical properties of the xenotropic murine leukemia virus-related virus integrase.
Mbemba G; Henry E; Delelis O; Bouger MC; Buckle M; Mouscadet JF; Hazan U; Leh H; Bury-Moné S
Biochimie; 2014 Dec; 107 Pt B():300-9. PubMed ID: 25260582
[TBL] [Abstract][Full Text] [Related]
4. Characterization, mapping, and distribution of the two XMRV parental proviruses.
Cingöz O; Paprotka T; Delviks-Frankenberry KA; Wildt S; Hu WS; Pathak VK; Coffin JM
J Virol; 2012 Jan; 86(1):328-38. PubMed ID: 22031947
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.
Matúz K; Mótyán J; Li M; Wlodawer A; Tőzsér J
FEBS J; 2012 Sep; 279(17):3276-86. PubMed ID: 22804908
[TBL] [Abstract][Full Text] [Related]
6. Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.
Li M; Gustchina A; Matúz K; Tözsér J; Namwong S; Goldfarb NE; Dunn BM; Wlodawer A
FEBS J; 2011 Nov; 278(22):4413-24. PubMed ID: 21951660
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of XMRV protease differs from the structures of other retropepsins.
Li M; Dimaio F; Zhou D; Gustchina A; Lubkowski J; Dauter Z; Baker D; Wlodawer A
Nat Struct Mol Biol; 2011 Feb; 18(2):227-9. PubMed ID: 21258323
[TBL] [Abstract][Full Text] [Related]
8. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
9. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.
Murgai M; Thomas J; Cherepanova O; Delviks-Frankenberry K; Deeble P; Pathak VK; Rekosh D; Owens G
Retrovirology; 2013 Mar; 10():34. PubMed ID: 23537062
[TBL] [Abstract][Full Text] [Related]
10. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.
Fehér A; Boross P; Sperka T; Miklóssy G; Kádas J; Bagossi P; Oroszlan S; Weber IT; Tözsér J
J Gen Virol; 2006 May; 87(Pt 5):1321-1330. PubMed ID: 16603535
[TBL] [Abstract][Full Text] [Related]
12. Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines.
Williams DK; Galvin TA; Ma H; Khan AS
Biologicals; 2011 Nov; 39(6):378-83. PubMed ID: 21996050
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors.
Qiu X; Swanson P; Tang N; Leckie GW; Devare SG; Schochetman G; Hackett J
Transfusion; 2012 Feb; 52(2):307-16. PubMed ID: 22023235
[TBL] [Abstract][Full Text] [Related]
14. Generation of multiple replication-competent retroviruses through recombination between PreXMRV-1 and PreXMRV-2.
Delviks-Frankenberry K; Paprotka T; Cingöz O; Wildt S; Hu WS; Coffin JM; Pathak VK
J Virol; 2013 Nov; 87(21):11525-37. PubMed ID: 23966380
[TBL] [Abstract][Full Text] [Related]
15. No evidence of cross-species transmission of mouse retroviruses to animal workers exposed to mice.
Brooks J; Lycett-Lambert K; Caminiti K; Merks H; McMillan R; Sandstrom P
Transfusion; 2012 Feb; 52(2):317-25. PubMed ID: 22212105
[TBL] [Abstract][Full Text] [Related]
16. The role of the structural domains of human BST-2 in inhibiting the release of xenotropic murine leukemia virus-related virus.
Hu S; Pang X; Li J; Cen S; Jin Q; Guo F
Biochem Biophys Res Commun; 2012 Nov; 428(1):17-23. PubMed ID: 23047007
[TBL] [Abstract][Full Text] [Related]
17. Absence of xenotropic murine leukemia virus-related virus in blood donors in China.
Mi Z; Lu Y; Zhang S; An X; Wang X; Chen B; Wang Q; Tong Y
Transfusion; 2012 Feb; 52(2):326-31. PubMed ID: 21854397
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
19. The saga of XMRV: a virus that infects human cells but is not a human virus.
Arias M; Fan H
Emerg Microbes Infect; 2014 Apr; 3(4):e. PubMed ID: 26038516
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.
Hong P; Li J
Virus Res; 2012 Jul; 167(1):1-7. PubMed ID: 22531412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
